The Internet Society is a longtime supporter of the IGF. We believe that the opportunities we can create by coming together with diverse stakeholders around common themes can help us combat the ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
More information: Christopher Godina et al, Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression, npj Precision Oncology (2024). DOI ...
Reference: “Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression” by Christopher Godina, Michael N. Pollak and Helena Jernström, 3 October 2024, npj ...
The IR world was rocked by the news earlier this month that Lorne Gorber, senior adviser and Quebec lead at LodeRock and former ...
The San Francisco 49ers on Saturday officially placed running back Jordan Mason on IR as part of a slew of roster moves leading up to a Week 14 matchup against the Chicago Bears. Mason suffered a ...
In recent years, an increasing number of studies have utilized molecular biology techniques to reveal important molecular heterogeneity among different subtypes of liposarcoma. Each subtype exhibits ...
Results for all three TransCon hGH starting dose cohorts, in first clinical trial of an indication outside of growth hormone ...
A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development ...
You are free to share (copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must ...
Subcutaneous VRDN-003, a Potential Best-In-Class Anti-IGF-1R, On Track to Report Topline 1H 2026 VRDN-003 is an IGF-1R antibody with the same binding domain as veligrotug and is believed to be the ...